Bausch Health Companies | Pasivo Circulante



Current Liabilities Cambio Fecha
Amgen USD 20.48B 2.53B 2025-06
ANI Pharmaceuticals USD 236.83M 35.02M 2025-06
Aurora Cannabis CAD 149.81M 40.71M 2024-12
Bausch Health Companies USD 4.98B 719M 2025-06
Biogen USD 3.18B 2.11B 2025-06
Bristol-Myers Squibb USD 27.53B 3.46B 2025-06
Canopy Growth CAD 97.02M 184.27M 2024-12
Corcept Therapeutics USD 144.66M 1.6M 2025-06
Danaher USD 6.79B 147M 2025-06
Drreddys Laboratories INR 131.95B 2.65B 2024-12
Eli Lilly USD 39.02B 8.95B 2025-06
Gilead Sciences USD 11.19B 1.15B 2025-06
Novo Nordisk 207.52B 28.6B 2025-06
Pacira USD 313.16M 1.57M 2025-06
Perrigo USD 1.13B 52.3M 2025-06
Prestige Brands USD 109.67M 3.04M 2025-06
Supernus Pharmaceuticals USD 286.36M 4.59M 2025-06
Vertex Pharmaceuticals USD 4.14B 355.2M 2025-06
Zoetis USD 3.37B 19M 2025-06


Bausch Health Companies Pasivo Circulante - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Aug 2025.